NEW YORK (GenomeWeb News) - Caliper Life Sciences today said second-quarter revenues increased 45 percent as R&D spending grew 35 percent and net loss more than tripled.
 
Total receipts for the three months ended June 30 increased to $35.3 million from $24.3 million year over year.
 
Product sales contributed $21 million, a 71 percent increase year over year; services brought in $8.9 million, a 66 percent increase; and licensing and contracts fell 20 percent to $5.3 million.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.